Disease Component | GATA3 staininga | Â | GCDFP15 staininga | Â | P value | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0 | 1+ | 2+ | 3+ | 4+ | Total | 0 | 1+ | 2+ | 3+ | 4+ | Total | ||
Intraepithelial disease (NÂ =Â 34) | 0 | 2 (6%) | 1 (3%) | 3 (9%) | 28 (82%) | 34 (100%) | 6 (8%) | 12 (35%) | 4 (12%) | 4 (12%) | 8 (24%) | 28 (82%) | 0.0004# |
 Type Ia (N = 24) |  | 1 |  | 3 | 20 | 4 | 8 | 4 | 3 | 5 |  |  | |
 Type Ib (N = 5) |  |  | 1 |  | 4 | 1 | 3 |  |  | 1 |  |  | |
 Type Ic (N = 5) |  | 1 |  |  | 4 | 1 | 1 |  | 1 | 2 |  |  | |
Invasive adenocarcinoma(NÂ =Â 10) | 0 | 0 | 2 (20%) | 0 | 8 (80%) | 10 (10%) | 1 (10%) | 3 (30%) | 0 | 1 (10%) | 5 (50%) | 9 (90%) | 0.1035# |
 type Ib (N = 5) |  |  |  |  | 5 |  |  | 1 |  | 1 | 3 |  |  |
 type Ic (N = 5) |  |  | 2 |  | 3 |  | 1 | 2 |  |  | 2 |  |  |
Metastatic adenocarcinoma (NÂ =Â 3) | 0 | 0 | 0 | 0 | 3 (100%) | 3 (100%) | 1 (33%) | 1 (33%) | 0 | 0 | 1 (33%) | 2 (67%) | not applicable |